TNFRSF8 and Hodgkins lymphoma: Therefore, [89Zr]Zr-DFO-BV was also reported to be a promising agent for the noninvasive determination of CD30 expression in lung cancer.304 Dietlein et al. compared new anti-CD30 radioimmunoconjugates of vary structures radiolablled with iodine-131 in Hodgkin lymphoma xenografts.